We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bioscience Vct | LSE:BVP | London | Ordinary Share | GB0031256109 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Dividend Declaration
Seneca Growth Capital VCT Plc
7 March 2023
Seneca Growth Capital VCT Plc
Interim Dividend Declarations
The Directors of Seneca Growth Capital VCT Plc (the “Company”) are pleased to declare the following dividends for both the B Share Class and the Ordinary Share Class for the year to 31 December 2023:
The ex-dividend date for both dividends is 4 May 2023.
The record date for both dividends is 5 May 2023.
The payment date for both dividends is 19 May 2023.
On 26 August 2022 the Company launched an offer for subscription for B Shares to raise, in aggregate, up to £10 million with an over-allotment facility of up to a further £10 million (before issue costs) (the "Offer"). Full details of the Offer are contained in a prospectus issued by the Company on that date (the "Prospectus").
In relation to the B Share Offer, investors seeking to benefit from the above B Share dividend should note the following:
A copy of the Prospectus, and the application form, is available on the Company's website: https://senecavct.co.uk/current-offer/
This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, this information is now considered to be in the public domain.
For further information, please contact:
Matt Currie, Seneca Partners Limited at Matt.Currie@senecapartners.co.uk
Siobhan Pycroft, Seneca Partners Limited at Siobhan.Pycroft@senecapartners.co.uk
1 Year Bioscience Vct Chart |
1 Month Bioscience Vct Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions